Sign Up to like & get
recommendations!
1
Published in 2020 at "Clinical Cancer Research"
DOI: 10.1158/1078-0432.ccr-20-0645
Abstract: Purpose: Resistance to treatment with endocrine therapy in patients with HR+, HER2− advanced breast cancer (ABC) is common and dual inhibition of CDK4/6 and PI3K pathways may delay the development of resistance. This phase Ib…
read more here.
Keywords:
ribociclib;
ribociclib plus;
cancer;
fulvestrant ribociclib ... See more keywords